GlassScriptPhysician profile
Kyle K Karnish
NPI 1912285750
$6,676.69
in general payments reported to CMS, 2019-2025
10 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,220 · 2020: $74.02 · 2021: $269 · 2022: $553 · 2023: $396 · 2024: $713 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292 · Entertainment: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,292.36 |
| Entertainment | $268.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $4,691.46 | 2019-2025 | Myday Contact Lens |
| Alcon Vision LLC | $857.19 | 2019-2025 | Total30, Precision 1, Precision7 |
| Optos, INC. | $389.47 | 2021-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $307.66 | 2022-2025 | Biotrue One Day, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.39 | 2019 | |
| Abb Con-Cise Optical Group LLC | $94.92 | 2019-2024 | Contact Lens, Spectacle Lenses |
| Johnson & Johnson Vision Care, INC. | $83.87 | 2019-2024 | Acuvue |
| Allergan, INC. | $67.41 | 2022 | |
| Ocular Therapeutix, INC. | $28.75 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Karnish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.